You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Clinical Trial Search Results

Baystate has clinical trials in several medical specialties. Clinical trials can help our patients by making advanced care available to them right in their communities.

Is volunteering for a clinical trial right for you? Learn more.

Page 2 of 8 | Results 11 - 20 of 72

A phase II/III biomarker-driven trial for Second Line Therapy of Squamous Cell Lung Cancer

John McCann, MD
Cancer, Cancer - Lung

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A phase III trial of adjuvant radiation vs. chemotherapy radiation in intermediate risk; stage I/II cervical cancer

Tashanna Myers, MD
Cancer, Cancer-Gynecologic

  • D’Amour Center for Cancer Care, 3350 Main Street , Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA
  • Baystate Mary Lane Outpatient Center, 85 South Street, Ware, MA

A phase III trial of medications for castration resistance in metastatic prostate cancer

The purpose of this study is to compare the effects, good and/or bad, of abiraterone, prednisone, and enzalutamide with enzalutamide alone on you and your prostate cancer to find out which is better.
Leslie Howard, MD
Cancer - Prostate, Cancer

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA

Active

A phase III trial to combine the effects of a group of medications with another combination in patients with newly diagnosed Symptomatic Multiple Myeloma

This randomized phase III trial studies lenalidomide, dexamethasone, and bortezomib to see how well it works compared to dexamethasone and lenalidomide alone in treating patients with previously untreated multiple myeloma. Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth or by blocking blood flow to the cancer. It is not yet known whether lenalidomide and dexamethasone is more effective with or without bortezomib in treating multiple myeloma.
Syed Ali, MD
Cancer - Leukemia, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A phase III trial to evaluate adjuvant chemotherapy following Chemoradiation as treatment for locally advanced cervical cancer

The purpose of this study is to compare standard treatment, radiation therapy combined with the chemotherapy drug cisplatin, to standard chemo-radiation therapy plus additional experimental chemotherapy to see if it reduces the risk of tumor recurrence and improves overall survival.
Tashanna Myers, MD
Cancer-Gynecologic, Cancer

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A phase III trial to study Esophageal Adenocarcinoma

Seth Kaufman, MD
Cancer - Esophogus, Cancer

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Active

A phase III trial to study stage IV squamous cell lung cancer

John McCann, MD
Cancer, Cancer - Lung

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A phase III trial to study surgically resected early stage non-small cell lung cancer patients

John McCann, MD
Cancer, Cancer - Lung

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A phase IV trial of a chemotherapeutic agent in patients with recurrent or stage IV non-small cell lung cancer whose tumors may have unique mutations

John McCann, MD
Cancer, Cancer - Lung

D’Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

A randomized multi-center study to evaluate the safety and efficacy of a study drug in subjects with severe sepsis

The purpose of this study is to evaluate the safety and potential efficacy signal of the study drug, BMS-936559, in subjects with severe sepsis.

Tidswell, Mark, MD
Infection

Baystate Medical Center, 759 Chestnut Street, Springfield, MA

Page 2 of 8 | Results 11 - 20 of 72